Skip to main content
Log in

Breast cancer STAs becoming more compliant with NICE methods

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. National Institute for Health and Care Excellence

Reference

  • Rose M, et al. Does Methodological Guidance Produce Consistency? A Review of Methodological Consistency in Breast Cancer Utility Value Measurement in NICE Single Technology Appraisals. PharmacoEconomics-Open : 5 Jul 2017. Available from: URL: http://dx.doi.org/10.1007/s41669-017-0040-5

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Breast cancer STAs becoming more compliant with NICE methods. PharmacoEcon Outcomes News 782, 11 (2017). https://doi.org/10.1007/s40274-017-4142-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4142-1

Navigation